Hypotriglyceridemic Effect of Anka (a Fermented Rice Product ofMonascussp.) in Rats
- 15 July 2000
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 48 (8) , 3183-3189
- https://doi.org/10.1021/jf9909353
Abstract
Experimental rats with hypertriglyceridemia were prepared by feeding a high-fructose diet. Dried Anka powder (2%), a rice product fermented with Monascus sp., was mixed with basic high-fructose (30%) or basal-diet feed. Serum and liver lipids were measured after 6 months. The concentrations of serum triglycerides, total cholesterol, VLDL-C, and LDL-C had significantly decreased, whereas that of HDL-C had slightly increased in 30% fructose−Anka-fed rats as compared with the 30% fructose-fed rats, but hepatic lipase activity had increased in the Anka-fed groups. The ratio of lipoprotein lipase/hepatic lipase was not significantly different between 30% fructose−Anka-fed rats and 30% fructose-fed rats. The dietary intake and weight of these two groups were approximately the same. Similar results were obtained in noninduced hypertriglyceridemic rats. The concentrations of triglycerides and cholesterol did not significantly differ in the liver. Interestingly, Anka can suppress serum triglycerides in rats with induced hypertriglyceridemia. The antioxidant enzyme SOD activity was also measured in serum, and no significant change was observed. On the basis of these findings, we suggest that Anka may be used to suppress hypertriglyceridemia and hyperlipidemia in rats and possibly in man. Keywords: Anka; Monascus sp.; hypertriglyceridemia; triglyceride; cholesterol; VLDL-C; LDL-C; HDL-C; lipoprotein lipase; hepatic lipase; SODKeywords
This publication has 22 references indexed in Scilit:
- Oxidized Low Density Lipoproteins in Atherogenesis: Role of Dietary ModificationAnnual Review of Nutrition, 1996
- Triglyceride lpases and atherosclerosisCurrent Opinion in Lipidology, 1995
- Composition of human low density lipoprotein: Effects of postprandial triglyceride-rich lipoproteins, lipoprotein lipase, hepatic lipase and cholesteryl ester transfer proteinAtherosclerosis, 1993
- Single risk factor intervention may be inadequate to inhibit atherosclerosis progression when hypertension and hypercholesterolemia coexist.Hypertension, 1991
- Increased apo A-I and apo A-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia.Journal of Clinical Investigation, 1991
- Compactin (ML-236B) and related compounds as potential cholesterol-lowering agents that inhibit HMG-CoA reductaseJournal of Medicinal Chemistry, 1985
- Monacolin K, a new hypocholesterolemic agent that specifically inhibits 3-hydroxy-3-methylglutaryl coenzyme A reductase.The Journal of Antibiotics, 1980
- Monacolin K, a new hypocholesterolemic agent produced by a Monascus species.The Journal of Antibiotics, 1979
- Serum lipids, hypertension and coronary artery diseaseThe American Journal of Medicine, 1961
- Hypercholesteremia with predisposition to atherosclerosis: An inborn error of lipid metabolismThe American Journal of Medicine, 1951